Abstract

BackgroundTreatments for perimembranous ventricular septal defects (pmVSD) mainly include conventional surgical repair (CSR), transcatheter device closure (TDC), and perventricular device closure (PDC). We aimed to perform a network meta-analysis to compare the three approaches in patients with pmVSD.MethodsWe searched for comparative studies on device closure and conventional repair for pmVSD to April 2020. A network meta-analysis was performed under the frequentist frame with risk ratio and 95% confidence interval. The main outcome was the procedural success rate. Additional outcomes were postoperative complications, including residual shunt, intra-cardiac conduction block, valvular insufficiency, incision infection, and pericardial effusion.ResultsTwenty-four studies of 8113 patients were included in the comparisons. The pooled estimates of success rate favored the CSR compared with the PDC. No significant differences of success rate were found in the TDC versus CSR and the PDC versus TDC. The pooled estimates of incidences of the residual shunt, new tricuspid regurgitation, incision infection, and pericardial effusion favored the PDC compared with the CSR. There were no significant differences between the PDC and TDC approaches in all outcomes except new aortic regurgitation.ConclusionThe PDC technique not only reduces the risk of significant complications compared with the CSR, but also produces not inferior results compared with the TDC in selected pmVSD patients.PROSPERO registration numberCRD42019125257.

Highlights

  • Treatments for perimembranous ventricular septal defects mainly include conventional surgical repair (CSR), transcatheter device closure (TDC), and perventricular device closure (PDC)

  • Devices became available that can be delivered through a percutaneous or perventricular approach to close these defects without cardiopulmonary bypass, especially in muscular VSDs (mVSD) and perimembranous ventricular septal defects (pmVSD) [7, 8]

  • Study selection A total of 24 studies involving 8113 patients were included in comparisons

Read more

Summary

Introduction

Treatments for perimembranous ventricular septal defects (pmVSD) mainly include conventional surgical repair (CSR), transcatheter device closure (TDC), and perventricular device closure (PDC). Isolated ventricular septal defects (VSDs) are the most common congenital heart diseases accounting for 20– 30% of all congenital cardiac malformations [1, 2]. Open-heart surgical repair requires cardiopulmonary bypass as well as total sternotomy, which is physically and psychologically traumatic, especially for pediatric patients [6]. Under this circumstance, devices became available that can be delivered through a percutaneous or perventricular approach to close these defects without cardiopulmonary bypass, especially in mVSD and pmVSD [7, 8]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call